Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban

Lancet

Volumn 354, Issue 9192, 1999, Pages 1757-1762

  Heeschen, Christopher ^a   Hamm, Christian W ^b   Goldmann, Britta ^c   Deu, Ariane ^c   Langenbrink, Lukas ^c   White, Harvey D ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KERCKHOFF HEART CENTER   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; HEPARIN; NITRATE; TIROFIBAN; TROPONIN I; TROPONIN T;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK;

EID: 0033589739     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)10285-X     Document Type: Article

References (34)

1. Braunwald E., Jones R.H., Mark D.B.et al. Diagnosing and managing unstable angina. Circulation. 90:1994;613-622.
2. Braunwald E. Unstable angina: an etiologic approach to management. Circulation. 98:1998;2219-2222.
3. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 349:1997;1429-1435.
4. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 338:1998;1498-1505.
5. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 338:1998;1488-1497.
6. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 96:1997;1445-1453.
7. Davies M.J., Thomas A.C. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemia mortality, and crescendo angina. Br Heart J. 53:1985;363-373.
8. Farb A., Burke A.P., Tang A.L.et al. Coronary plaque erosion without rupture into a lipid core. Circulation. 93:1996;1354-1363.
9. Davies M.J. The composition of coronary-artery plaques. N Engl J Med. 336:1997;1312-1313.
10. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and / or sudden mortality: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 71:1985;699-708.
11. Davies M.J., Thomas A.C., Knapman P.A., Hangartner J.R. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac mortality. Circulation. 73:1986;418-427.
12. Peerlinck K., De Lepeleire I., Goldberg M.et al. MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation. 88:1993;1512-1517.
13. Lynch J.J. Jr., Cook J.J., Sitko G.R.et al. Nonpeptide glycoprotein IIb/IIIa inhibitors, 5: antithrombotic effects of MKI-0383. J Pharmacol Exp Ther. 272:1995;20-32.
14. Hamm CW, Heeschen C, Goldmann, BU, et al. for the CAPTURE Study investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340: 1623-29.
15. Katus H.A., Remppis A., Neumann F.J.et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
16. Antman E.M., Tanasijevic M.J., Thompson B.et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.
17. Hamm C.W., Goldmann B.U., Heeschen C., Kreyman G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin, T. and or troponin, I. N Engl J Med. 337:1997;1648-1653.
18. Hamm C.W., Ravkilde J., Gerhardt W.et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
19. Lindahl B., Venge P. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombtic protection. J Am Coll Cardiol. 29:1997;43-48.
20. Luescher M.S., Thygesen K., Ravkilde J., Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary disease. Circulation. 96:1997;2578-2585.
21. Ohman E.M., Armstrong P.W., Christenson R.H.et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
22. Pettijohn T.L., Doyle T., Spiekerman A.M., Watson L.E., Riggs M.W., Lawrence M.E. Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris. Am J Cardiol. 80:1997;510-511.
23. Ravkilde J., Nissen H., Horder M., Thygesen K. Independent prognostic value of plasma creatine kinase isoenzyme, MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. J Am Coll Cardiol. 25:1995;574-581.
24. Stubbs P., Collinson P., Path M.R.C., Moseley D., Greenwood T., Noble M. Prognostic significance of admission troponin, T concentrations in patients with myocardial infarction. Circulation. 94:1996;1291-1297.
25. Wu A., Abbas S.A., Green S.et al. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol. 76:1995;970-1002.
26. Benamer H., Steg P.G., Benessiano J.et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J. 137:1999;815-820.
27. Heeschen C., van den Brand M.J., Hamm C.W., Simoons M.L. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation. 100:1999;1509-1514.
28. Apple F.S., Maturen A.J., Mullins R.E.et al. Multicenter clinical and analytical evaluation of the AxSYM Troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem. 45:1999;206-212.
29. Katus H.A., Looser S., Hallermayer K.et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 38:1992;386-393.
30. Mueller-Bardorff M., Hallermayer K., Schroeder A.et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. J Clin Chem. 43:1997;458-466.
31. Gerhardt W., Katus H., Ravkilde J.et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S creatine kinase isoenzyme, MB. Clin Chem. 37:1991;1405-1411.
32. Klein G., Kampmann M., Baum H.et al. Clinical performance of the new cardiac markers troponin T and CK-MB on the Elecsys: 2010 a multicentre evaluation. Wien Klin Wochenschr. 3:1998;40-51.
33. Hosmer D.W., Lemeshow S. Applied logistic regression. 1989;John Wiley, New York.
34. Harrel F.E., Lee K.L., Polloch B.G. Regression models in clinical studies: determining relationships between predictors and response. Nat Cancer Inst. 80:1988;1198-1202.